SNA02-48 + tetanus toxoid

SNA02-48 + tetanus toxoid is a combination vaccine comprising SNA02-48 and tetanus toxoid. Tetanus toxoid is an inactivated form of tetanus toxin produced from *Clostridium tetani*, which is detoxified with formaldehyde. It stimulates the immune system to produce antibodies against tetanus, conferring protective immunity. Tetanus toxoid is a legacy, clinically effective vaccine and is often used as a carrier protein in conjugate vaccine formulations for small molecules, peptides, or polysaccharides. The mechanism of action is through active immunization by eliciting a humoral immune response without causing the pathogenic effects of the toxin. SNA02-48 is presumed to be a novel or experimental antigen or conjugate, but no detailed public data are available on its composition or biological effects. The combination likely serves as a vaccine candidate in which tetanus toxoid may act both as an immunogen and possibly a carrier protein, with the goal of inducing protective immunity either to tetanus alone or to additional targets via SNA02-48[2][4].